Aitor Alapont, CEO of P4Q Health: “With the support of CDTI Innovation we are bringing the diagnosis of reproductive hormones to the home environment”

Digitalization is profoundly transforming the healthcare environment, opening the door to more accessible, personalized and patient-centered models. In this context, female reproductive health represents one of the areas with the greatest potential for innovation, especially with regard to access to reliable information and the possibility of continuous monitoring outside the clinical environment.

In this line, the PT FERT project was born, promoted by P4Q Health —a specialized health unit of the Kinematics group, formerly known as P4Q— with the support of CDTI Innovation, focused on the development of a digital platform for the detection of female reproductive hormones from the domestic environment, maintaining standards of clinical precision.

The aim of the project is to transfer to the domestic environment evidence that has hitherto been restricted to the clinical environment, facilitating access to reliable information on reproductive health quickly and easily. 
 

Image

Facilities of P4Q Health, where advanced technological solutions are developed in the field of health

From industrial technology to personalized health

The project is based on the technological trajectory of the Kinematics group, with experience in advanced electronics, IoT and cloud data analysis, capabilities that have been key to the development of the platform promoted within the framework of the PT FERT project.

On this basis, the company has evolved into the biomedical field with a clear objective: to transfer that knowledge to solutions with a direct impact on people’s lives. “Since our inception, we have had a clear purpose: to develop technology focused on people, capable of improving their daily lives and generating a real and tangible impact,” explains Aitor Alapont, CEO of P4Q Health.

This vision translates into the development of a digital ecosystem that allows the user to better understand their state of health and make informed decisions, moving towards a more preventive and personalized model. 
 

Women’s health at the heart of innovation

The origin of the project is directly linked to a detected need in the field of women's health. Based on technologies already developed by the company for the measurement of biomarkers, the team identified the potential to apply these solutions to hormonal monitoring.

The initiative arises after verifying, through contact with patients, healthcare professionals and their network of collaborators, the growing interest in tools that allow a closer monitoring of hormone levels throughout the different stages of the life cycle. "This initiative was born with a very clear objective: to offer women something essential and, often, undervalued in health care, tranquility," says Alapont.

The project thus responds not only to a technological challenge, but also to the need to move towards more inclusive and personalized care models, reinforcing the role of innovation in improving women's health. 
 

A digital ecosystem for home diagnostics

Within the framework of the PT FERT project, P4Q Health is working on the development of a digital platform that integrates different technological elements into a single solution: a digital reader with spectrometric sensor, tests based on immunofluorescence and a mobile application that allows to visualize and interpret the results. "This ecosystem allows accurate and reliable measurements to be obtained in minutes, facilitating an agile diagnostic experience for both the healthcare professional and the patient," explains the CEO.

The system allows quantitative results to be obtained in a matter of minutes, which facilitates both patient use and clinical decision making, bringing the laboratory’s own capabilities closer to the home environment.

This progress is aligned with the Sustainable Development Goals (SDGs), more specifically with SDG 3: Health and Wellness, facilitating access to faster, more accessible and patient-centered diagnostic tools. 
 

Innovation to overcome technical challenges

One of the main challenges of the PT FERT project has been to adjust hormonal analyses to the use of capillary blood, a more complex environment than the traditional laboratory. "Tests must be adapted to make them compatible with blood samples. In optical dependent systems, the quality of the signal obtained is especially important," explains Alapont.

Added to this is the need to reduce the sample volume as much as possible to facilitate its use in domestic environments, which requires the optimization of detection systems. "Reducing the sample volume makes the detection of the target analyte more complicated," he adds.

This continuous improvement process, based on design and validation iterations, reflects the R&D intensive nature of the project. 
 

Designing with the user in mind

Beyond technology, one of the pillars of development has been the user experience. The company has worked directly with patients to adapt the solution to their real needs. "Usability is a key aspect in the development of such solutions. It is not enough for the technology to work, it has to be easy to use, understandable and build trust," says the CEO.

In this sense, the team has been adjusting both the device and the application to ensure an intuitive experience. “We rely heavily on user feedback. It’s what allows us to improve and really get closer to what they need,” he explains. 
 

International collaboration and scientific development

The project also relies on the collaboration of Sun Yat-sen University, a leading institution in biomedical research. "Our partners in China contribute to the design of immunoassays, bringing their extensive experience in the industry," explains Alapont.

The combination of industrial, technological and scientific capabilities allows development to be approached from a multidisciplinary perspective. 
 

Impact on patients and healthcare professionals

The solution developed by P4Q Health within the framework of PT FERT has a direct impact on both patients and healthcare professionals. In the words of the CEO: "Our solution allows patients to access quantitative information in real time, significantly reducing waiting times that, in many cases, generate uncertainty and anxiety."

In addition, the less invasive nature of the test facilitates its frequent use, favoring more continuous monitoring. From a clinical point of view, the immediate availability of quantitative data makes it possible to optimize decision making and reduce dependence on external laboratories. 
 

The role of the CDTI Innovation

The development of PT FERT has been promoted by the CDTI Innovation, whose role has been decisive in promoting the initiative. "The support of the CDTI has been a key element for the scalability of the project," says Alapont, adding: “It has allowed us to strengthen our talent structure and accelerate the development, validation and industrialization of the solution.”

In this sense, the CDTI acts as a catalyst for innovation, helping to promote technological projects with an impact on society. 
 

The future: data, prevention and autonomy

Looking ahead, P4Q Health will continue to make progress in developing solutions that place the patient at the heart of the healthcare system, with initiatives such as the PT FERT project, aimed at improving access to reliable information and facilitating more continuous and personalized health monitoring.

“The future of P4Q Health hinges on a very clear goal: empowering people to regain sovereignty over their own health,” concludes Alapont.

In this sense, the development of platforms such as PT FERT marks a step forward towards more preventive, accessible and data-based care models, in which the diagnosis is naturally integrated into the patient's daily life.
 

Image

Reader device developed by P4Q Health in the field of digital diagnosis, oriented to the monitoring of biomarkers

CDTI Innovation

The Center for Technological Development and Innovation, CDTI E.P.E. It is the innovation agency of the Ministry of Science, Innovation and Universities, whose objective is the promotion of technological innovation in the business environment. The mission of the CDTI is to ensure that the Spanish business fabric generates and transforms scientific and technical knowledge into globally competitive, sustainable and inclusive growth. In 2025, within the framework of the Strategic Plan 2024-2027, the CDTI provided more than 2 billion euros of support to Spanish companies and startups.
 

More information:

Press Office
press@cdti.es
91-581.55.00

On the Internet
Website: www.cdti.es
On Linkedin: https://www.linkedin.com/company/29815
On X: https://x.com/CDTI_innovacion
On Youtube: https://www.youtube.com/user/CDTIoficial

This content is copyright © 2026 CDTI,EPE. The use and reproduction is allowed by citing the source and digital identity of CDTI (@CDTI_innovacion).